Gilead Sciences, Inc. Announces First Quarter 2013 Financial Results
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the quarter ended March 31, 2013. Total revenues for the first quarter of 2013 increased 11 percent to $2.53 billion, from $2.28 billion for the first quarter of 2012. Product sales increased 8 percent to $2.39 billion for the first quarter of 2013 compared to $2.21 billion for the first quarter of 2012. Net income for the first quarter of 2013 was $722.2 million, or $0.43 per diluted share compared to $442.0 million, or $0.28 per diluted share for the first quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the quarter ended March 31, 2013. Total revenues for the first quarter of 2013 increased 11 percent to $2.53 billion, from $2.28 billion for the first quarter of 2012. Product sales increased 8 percent to $2.39 billion for the first quarter of 2013 compared to $2.21 billion for the first quarter of 2012. Net income for the first quarter of 2013 was $722.2 million, or $0.43 per diluted share compared to $442.0 million, or $0.28 per diluted share for the first quarter of 2012.
Help employers find you! Check out all the jobs and post your resume.